TW201717785A - 降低卡路里用組成物 - Google Patents

降低卡路里用組成物 Download PDF

Info

Publication number: TW201717785A
Authority: TW; Taiwan
Prior art keywords: composition; peptide; reducing; calorie; salt
Prior art date: 2015-06-30

Application number

TW105120771A

Other languages

English (en)

Chinese (zh)

Inventor

Shinya Fukizawa

Toshihide Suzuki

Hiroshi Watanabe

Mitsuhiro Zeida

Original Assignee

Suntory Holdings Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-06-30

Filing date

2016-06-30

Publication date

2017-06-01

2016-06-30 Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd

2017-06-01 Publication of TW201717785A publication Critical patent/TW201717785A/zh

Links

239000000203 mixture Substances 0.000 title claims abstract description 79
125000004122 cyclic group Chemical group 0.000 claims abstract description 70
150000003839 salts Chemical class 0.000 claims abstract description 33
235000013305 food Nutrition 0.000 claims abstract description 22
150000001413 amino acids Chemical class 0.000 claims abstract description 13
108090000765 processed proteins & peptides Proteins 0.000 claims description 45
238000000034 method Methods 0.000 claims description 25
235000019577 caloric intake Nutrition 0.000 claims description 17
238000010438 heat treatment Methods 0.000 claims description 14
241001465754 Metazoa Species 0.000 claims description 10
238000004519 manufacturing process Methods 0.000 claims description 10
102000008186 Collagen Human genes 0.000 claims description 7
108010035532 Collagen Proteins 0.000 claims description 7
229920001436 collagen Polymers 0.000 claims description 7
241000196324 Embryophyta Species 0.000 claims description 6
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
239000007788 liquid Substances 0.000 claims description 5
239000007787 solid Substances 0.000 claims description 5
235000010469 Glycine max Nutrition 0.000 claims description 4
244000068988 Glycine max Species 0.000 claims description 4
240000005979 Hordeum vulgare Species 0.000 claims description 4
235000007340 Hordeum vulgare Nutrition 0.000 claims description 4
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 4
244000269722 Thea sinensis Species 0.000 claims description 4
239000000470 constituent Substances 0.000 claims description 4
239000000284 extract Substances 0.000 claims description 4
239000004471 Glycine Substances 0.000 claims description 3
235000013353 coffee beverage Nutrition 0.000 claims description 3
241001107116 Castanospermum australe Species 0.000 claims description 2
240000007154 Coffea arabica Species 0.000 claims description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
244000000231 Sesamum indicum Species 0.000 claims description 2
235000006468 Thea sinensis Nutrition 0.000 claims description 2
235000021307 Triticum Nutrition 0.000 claims description 2
244000098338 Triticum aestivum Species 0.000 claims description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
239000005862 Whey Substances 0.000 claims description 2
102000007544 Whey Proteins Human genes 0.000 claims description 2
108010046377 Whey Proteins Proteins 0.000 claims description 2
235000021279 black bean Nutrition 0.000 claims description 2
235000007215 black sesame Nutrition 0.000 claims description 2
235000020279 black tea Nutrition 0.000 claims description 2
239000005018 casein Substances 0.000 claims description 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
235000021240 caseins Nutrition 0.000 claims description 2
235000016213 coffee Nutrition 0.000 claims description 2
-1 fluorenyl hydrazine Chemical compound 0.000 claims description 2
210000002826 placenta Anatomy 0.000 claims description 2
239000004474 valine Substances 0.000 claims description 2
MOEDDXVKEINTQF-BYPYZUCNSA-N (2s)-1-sulfanylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1S MOEDDXVKEINTQF-BYPYZUCNSA-N 0.000 claims 3
239000008247 solid mixture Substances 0.000 claims 2
235000020247 cow milk Nutrition 0.000 claims 1
OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 1
235000013361 beverage Nutrition 0.000 abstract description 10
AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 abstract description 5
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract description 5
235000001916 dieting Nutrition 0.000 abstract description 5
230000037228 dieting effect Effects 0.000 abstract description 5
229940097043 glucuronic acid Drugs 0.000 abstract description 5
239000000126 substance Substances 0.000 abstract description 5
208000001145 Metabolic Syndrome Diseases 0.000 abstract description 3
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 abstract description 3
108010016626 Dipeptides Proteins 0.000 abstract 2
239000000463 material Substances 0.000 description 27
210000002700 urine Anatomy 0.000 description 16
108010001140 cyclo(glycylprolyl) Proteins 0.000 description 14
239000002994 raw material Substances 0.000 description 12
OWOHLURDBZHNGG-YFKPBYRVSA-N (8ar)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione Chemical compound O=C1CNC(=O)[C@@H]2CCCN12 OWOHLURDBZHNGG-YFKPBYRVSA-N 0.000 description 11
235000001014 amino acid Nutrition 0.000 description 11
238000004458 analytical method Methods 0.000 description 8
239000007864 aqueous solution Substances 0.000 description 8
230000000694 effects Effects 0.000 description 8
239000012071 phase Substances 0.000 description 8
QHLSAVHDWSYPEP-VIFPVBQESA-N (3s)-3-[(4-hydroxyphenyl)methyl]piperazine-2,5-dione Chemical compound C1=CC(O)=CC=C1C[C@H]1C(=O)NCC(=O)N1 QHLSAVHDWSYPEP-VIFPVBQESA-N 0.000 description 7
QHLSAVHDWSYPEP-UHFFFAOYSA-N cyclo-Gly-L-Tyr Natural products C1=CC(O)=CC=C1CC1C(=O)NCC(=O)N1 QHLSAVHDWSYPEP-UHFFFAOYSA-N 0.000 description 7
238000002156 mixing Methods 0.000 description 7
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 6
BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical class OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 5
239000003814 drug Substances 0.000 description 5
229940079593 drug Drugs 0.000 description 5
230000029142 excretion Effects 0.000 description 5
238000004128 high performance liquid chromatography Methods 0.000 description 5
239000000243 solution Substances 0.000 description 5
239000002253 acid Substances 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 4
239000000047 product Substances 0.000 description 4
230000009467 reduction Effects 0.000 description 4
230000036325 urinary excretion Effects 0.000 description 4
NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
108010038807 Oligopeptides Proteins 0.000 description 3
102000015636 Oligopeptides Human genes 0.000 description 3
240000007594 Oryza sativa Species 0.000 description 3
235000007164 Oryza sativa Nutrition 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
235000013376 functional food Nutrition 0.000 description 3
210000001035 gastrointestinal tract Anatomy 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
239000000843 powder Substances 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
238000012552 review Methods 0.000 description 3
235000009566 rice Nutrition 0.000 description 3
239000002904 solvent Substances 0.000 description 3
235000013616 tea Nutrition 0.000 description 3
PNLUYLZSPGHNSN-YFKPBYRVSA-N 2-[3-[(2s)-3,6-dioxopiperazin-2-yl]propyl]guanidine Chemical compound NC(N)=NCCC[C@@H]1NC(=O)CNC1=O PNLUYLZSPGHNSN-YFKPBYRVSA-N 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 description 2
OWOHLURDBZHNGG-UHFFFAOYSA-N Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione Chemical compound O=C1CNC(=O)C2CCCN12 OWOHLURDBZHNGG-UHFFFAOYSA-N 0.000 description 2
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical group O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
208000008589 Obesity Diseases 0.000 description 2
241000700159 Rattus Species 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
238000011088 calibration curve Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
108010052299 cyclo(arginylglycyl) Proteins 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000037213 diet Effects 0.000 description 2
235000015872 dietary supplement Nutrition 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Chemical group OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
235000013399 edible fruits Nutrition 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
238000001914 filtration Methods 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
235000011389 fruit/vegetable juice Nutrition 0.000 description 2
XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
108010087823 glycyltyrosine Proteins 0.000 description 2
229960002591 hydroxyproline Drugs 0.000 description 2
230000006872 improvement Effects 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
238000005259 measurement Methods 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
235000020824 obesity Nutrition 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
239000002245 particle Substances 0.000 description 2
230000035699 permeability Effects 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000002265 prevention Effects 0.000 description 2
238000004445 quantitative analysis Methods 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
235000013322 soy milk Nutrition 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
239000003826 tablet Substances 0.000 description 2
238000004885 tandem mass spectrometry Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Chemical group ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
229940005605 valeric acid Drugs 0.000 description 2
CUQGPVWDPNMQEZ-ZDUSSCGKSA-N (2s)-2-(decylamino)pentanedioic acid Chemical compound CCCCCCCCCCN[C@H](C(O)=O)CCC(O)=O CUQGPVWDPNMQEZ-ZDUSSCGKSA-N 0.000 description 1
ORLDMMKUTCCBSM-UHFFFAOYSA-N (3S,6S)-3-methyl-6-(1-methylethyl)piperazine-2,5-dione Natural products CC(C)C1NC(=O)C(C)NC1=O ORLDMMKUTCCBSM-UHFFFAOYSA-N 0.000 description 1
WFDSWNXTPKLLOT-UHNVWZDZSA-N 2-[[(2s,4r)-4-hydroxypyrrolidin-1-ium-2-carbonyl]amino]acetate Chemical compound O[C@H]1CN[C@H](C(=O)NCC(O)=O)C1 WFDSWNXTPKLLOT-UHNVWZDZSA-N 0.000 description 1
QCKMEYKASJTMKI-ILCMOUOISA-N 2-aminoacetic acid;(2s)-2-aminopentanedioic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound NCC(O)=O.OC(=O)[C@@H]1CCCN1.OC(=O)[C@@H](N)CCC(O)=O QCKMEYKASJTMKI-ILCMOUOISA-N 0.000 description 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
229920000856 Amylose Polymers 0.000 description 1
206010003210 Arteriosclerosis Diseases 0.000 description 1
KQFADHLRBGGENK-UHFFFAOYSA-N C1(CCCCCCCCC1)C(C(C(=O)O)(O)NN)CC Chemical compound C1(CCCCCCCCC1)C(C(C(=O)O)(O)NN)CC KQFADHLRBGGENK-UHFFFAOYSA-N 0.000 description 1
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
241000725101 Clea Species 0.000 description 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
UKKNTTCNGZLJEX-WHFBIAKZSA-N Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UKKNTTCNGZLJEX-WHFBIAKZSA-N 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
201000001431 Hyperuricemia Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
ONPXCLZMBSJLSP-CSMHCCOUSA-N Pro-Hyp Chemical compound C1[C@H](O)C[C@@H](C(O)=O)N1C(=O)[C@H]1NCCC1 ONPXCLZMBSJLSP-CSMHCCOUSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
STTYIMSDIYISRG-UHFFFAOYSA-N Valyl-Serine Chemical compound CC(C)C(N)C(=O)NC(CO)C(O)=O STTYIMSDIYISRG-UHFFFAOYSA-N 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
235000013334 alcoholic beverage Nutrition 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
208000011775 arteriosclerosis disease Diseases 0.000 description 1
229940077388 benzenesulfonate Drugs 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
229940050390 benzoate Drugs 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014171 carbonated beverage Nutrition 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
229940106189 ceramide Drugs 0.000 description 1
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
235000021557 concentrated beverage Nutrition 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
108010083188 cyclo(prolylglycyl) Proteins 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
125000005594 diketone group Chemical group 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000008298 dragée Substances 0.000 description 1
235000005686 eating Nutrition 0.000 description 1
235000006694 eating habits Nutrition 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
238000000605 extraction Methods 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
230000037406 food intake Effects 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
235000015203 fruit juice Nutrition 0.000 description 1
239000000499 gel Substances 0.000 description 1
229930182480 glucuronide Natural products 0.000 description 1
150000008134 glucuronides Chemical class 0.000 description 1
230000005484 gravity Effects 0.000 description 1
238000000227 grinding Methods 0.000 description 1
239000007902 hard capsule Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
235000013402 health food Nutrition 0.000 description 1
108010050297 hydroxyprolyl-glycine Proteins 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229910017053 inorganic salt Inorganic materials 0.000 description 1
238000007689 inspection Methods 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
230000003870 intestinal permeability Effects 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
239000008274 jelly Substances 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000011344 liquid material Substances 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
229940049920 malate Drugs 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
GASFVSRUEBGMDI-UHFFFAOYSA-N n-aminohydroxylamine Chemical compound NNO GASFVSRUEBGMDI-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
150000002823 nitrates Chemical class 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
239000002417 nutraceutical Substances 0.000 description 1
235000021436 nutraceutical agent Nutrition 0.000 description 1
235000008935 nutritious Nutrition 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
229940075930 picrate Drugs 0.000 description 1
OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
239000006187 pill Substances 0.000 description 1
230000000291 postprandial effect Effects 0.000 description 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
238000004513 sizing Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007901 soft capsule Substances 0.000 description 1
239000011343 solid material Substances 0.000 description 1
235000011496 sports drink Nutrition 0.000 description 1
238000003756 stirring Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
239000007940 sugar coated tablet Substances 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000013076 target substance Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000014616 translation Effects 0.000 description 1
229940116269 uric acid Drugs 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
239000003643 water by type Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Mycology (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW105120771A 2015-06-30 2016-06-30 降低卡路里用組成物 TW201717785A (zh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2015131554		2015-06-30

Publications (1)

Publication Number	Publication Date
TW201717785A true TW201717785A (zh)	2017-06-01

Family

ID=57608856

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW105120771A TW201717785A (zh)	2015-06-30	2016-06-30	降低卡路里用組成物

Country Status (3)

Country	Link
JP (1)	JPWO2017002765A1 (fr)
TW (1)	TW201717785A (fr)
WO (1)	WO2017002765A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN119837994A (zh) *	2025-01-16	2025-04-18	广州中医药大学(广州中医药研究院)	一种环状二肽在改善或治疗血脂异常相关疾病中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5576653B2 (ja) *	2008-12-26	2014-08-20	サントリー食品インターナショナル株式会社	環状ジペプチド含有飲料
SG11201510062VA (en) *	2013-06-10	2016-01-28	Suntory Holdings Ltd	Plant extract containing diketopiperazine and method for producing same

2016
- 2016-06-27 JP JP2017526343A patent/JPWO2017002765A1/ja active Pending
- 2016-06-27 WO PCT/JP2016/069034 patent/WO2017002765A1/fr not_active Ceased
- 2016-06-30 TW TW105120771A patent/TW201717785A/zh unknown

Also Published As

Publication number	Publication date
WO2017002765A1 (fr)	2017-01-05
JPWO2017002765A1 (ja)	2018-04-12

Publication	Publication Date	Title
JP6796487B2 (ja)	2020-12-09	環状ジペプチド高含有組成物
AU2015275507A1 (en)	2017-01-05	Cyclic dipeptide-containing composition
TWI744240B (zh)	2021-11-01	含有環狀二肽及甜味料之組成物
TWI701031B (zh)	2020-08-11	含有胺基酸及環狀二肽之組成物
WO2017014153A1 (fr)	2017-01-26	Composition contre l'obésité comprenant un dipeptide cyclique
WO2015137387A1 (fr)	2015-09-17	Médicament d'amélioration musculaire
JP6661597B2 (ja)	2020-03-11	α−グルコシダーゼ阻害剤
TW201717785A (zh)	2017-06-01	降低卡路里用組成物
CN101795704B (zh)	2014-07-30	经口组合物
JP6770515B2 (ja)	2020-10-14	血圧降下用組成物
JP6687619B2 (ja)	2020-04-22	メラニン凝集ホルモン受容体拮抗用組成物
JP6515257B1 (ja)	2019-05-22	飲食用組成物
JP4673071B2 (ja)	2011-04-20	鉄吸着性高分子物質及び鉄含有高分子物質ならびにこれらの製造方法
JPWO2017002906A1 (ja)	2018-04-19	アルコール吸収抑制用組成物
US20220330595A1 (en)	2022-10-20	Angiotensin-converting enzyme inhibitor, blood pressure-lowering agent, and beverages and food products
JP7729581B2 (ja)	2025-08-26	肝機能向上剤および肝機能向上用経口組成物
CN111212639A (zh)	2020-05-29	包含芝麻酚和肽的缀合物作为活性成分的缓解宿醉的组合物
WO2009110464A1 (fr)	2009-09-11	Composition pour une amélioration de l'alimentation
WO2020149393A1 (fr)	2020-07-23	Procédé de sélection de substances améliorant l'odeur des matières fécales, procédé de fabrication de composition améliorant l'odeur des matières fécales, agent améliorant la fonction rénale, et boisson ou aliment destiné à améliorer la fonction rénale
HK1250630B (zh)	2022-04-29	含有环状二肽及甜味剂的组合物
HK40020447A (en)	2020-10-23	Hangover alleviating composition containing conjugate of sesamol and peptide as active ingredient
HK1250726B (zh)	2022-07-08	含有氨基酸及环状二肽的组合物